{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:08Z","timestamp":1792788608202,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Surgery"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.asjsur.2024.03.147","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T07:09:24Z","timestamp":1726470564000},"page":"4725-4734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of tenofovir versus entecavir on the long-term prognosis in hepatocellular carcinoma patients with concurrent metabolic dysfunction-associated steatotic liver disease and hepatitis B"],"prefix":"10.1016","volume":"47","author":[{"given":"Qingyan","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.asjsur.2024.03.147_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.asjsur.2024.03.147_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.asjsur.2024.03.147_bib3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.asjsur.2024.03.147_bib4","first-page":"354","article-title":"Epidemiological trends and clinical characteristic of NAFLD\/MAFLD in Asia","volume":"23","author":"Xue","year":"2022","journal-title":"J\u00a0Dig Dis"},{"issue":"1","key":"10.1016\/j.asjsur.2024.03.147_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2021-324915","article-title":"Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database","volume":"72","author":"Vitale","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.asjsur.2024.03.147_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.asjsur.2024.03.147_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.08.018","article-title":"Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: nationwide multigenerational cohort study","author":"Ebrahimi","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.asjsur.2024.03.147_bib8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1440-1746.2011.06801.x","article-title":"Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients","volume":"26","author":"Machado","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.asjsur.2024.03.147_bib9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/apt.16595","article-title":"Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B","volume":"54","author":"Zheng","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.asjsur.2024.03.147_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3350\/cmh.2022.0422","article-title":"Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: challenges and perspectives","volume":"29","author":"Huang","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1016\/j.asjsur.2024.03.147_bib11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41598-023-28351-3","article-title":"Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection","volume":"13","author":"Lv","year":"2023","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.asjsur.2024.03.147_bib12","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","article-title":"Association between nucleoside analogues and risk of hepatitis B virus\u2013related hepatocellular carcinoma recurrence following liver resection","volume":"308","author":"Wu","year":"2012","journal-title":"JAMA"},{"issue":"29","key":"10.1016\/j.asjsur.2024.03.147_bib13","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1200\/JCO.2012.48.5896","article-title":"Effect of antiviral treatment with nucleotide\/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study","volume":"31","author":"Yin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.asjsur.2024.03.147_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000525518","article-title":"Hepatitis B virus treatment and hepatocellular carcinoma: controversies and approaches to consensus","volume":"11","author":"Kim","year":"2022","journal-title":"Liver Cancer"},{"issue":"1","key":"10.1016\/j.asjsur.2024.03.147_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000518940","article-title":"Tenofovir is superior to entecavir on tertiary prevention for BCLC stage 0\/A hepatocellular carcinoma after curative resection","volume":"11","author":"Tsai","year":"2022","journal-title":"Liver Cancer"},{"issue":"3","key":"10.1016\/j.asjsur.2024.03.147_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/CM9.0000000000001864","article-title":"Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy","volume":"135","author":"Shen","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.asjsur.2024.03.147_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00535-022-01855-x","article-title":"Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection","volume":"57","author":"Wang","year":"2022","journal-title":"J\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.asjsur.2024.03.147_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.31289","article-title":"Tenofovir versus entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection","volume":"73","author":"Choi","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.asjsur.2024.03.147_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/17474124.2023.2212161","article-title":"Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"17","author":"Liu","year":"2023","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"23","key":"10.1016\/j.asjsur.2024.03.147_bib20","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1002\/cam4.4348","article-title":"Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a multicenter study","volume":"10","author":"Qi","year":"2021","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.asjsur.2024.03.147_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/liv.15086","article-title":"Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection","volume":"42","author":"Kim","year":"2022","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.asjsur.2024.03.147_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development?","volume":"76","author":"Wong","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.asjsur.2024.03.147_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.asjsur.2024.03.147_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41038-019-0170-3","article-title":"Analysis of t-test misuses and SPSS operations in medical research papers","volume":"7","author":"Liang","year":"2019","journal-title":"Burns Trauma"},{"issue":"2","key":"10.1016\/j.asjsur.2024.03.147_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjmed.2019.08.055","article-title":"Propensity score matching: the 'devil is in the details' where more may Be hidden than you know","volume":"133","author":"Reiffel","year":"2020","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.asjsur.2024.03.147_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.asjsur.2024.03.147_bib27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jhep.2009.07.009","article-title":"Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma","volume":"51","author":"Wu","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.asjsur.2024.03.147_bib28","first-page":"3032","article-title":"Tenofovir versus entecavir on the prognosis of hepatitis B-related hepatocellular carcinoma after surgical resection: a randomised controlled trial","volume":"109","author":"Linye","year":"2023","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.asjsur.2024.03.147_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2021-324915","article-title":"Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database","volume":"72","author":"Vitale","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.asjsur.2024.03.147_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-023-10545-6","article-title":"Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B","author":"Huang","year":"2023","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.asjsur.2024.03.147_bib31","article-title":"Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B","volume":"3","author":"van Kleef","year":"2021","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.asjsur.2024.03.147_bib32","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/hep.32792","article-title":"Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta-analysis","volume":"77","author":"Mao","year":"2023","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.asjsur.2024.03.147_bib33","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/apt.17438","article-title":"Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy","volume":"57","author":"Kao","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.asjsur.2024.03.147_bib34","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1002\/jmv.27977","article-title":"Real-life impact of tenofovir disoproxil fumarate and entecavir therapy on lipid profile, glucose, and uric acid in chronic hepatitis B patients","volume":"94","author":"Zhang","year":"2022","journal-title":"J\u00a0Med Virol"},{"issue":"1","key":"10.1016\/j.asjsur.2024.03.147_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000525911","article-title":"Discriminatory changes in circulating metabolites as a predictor of hepatocellular cancer in patients with metabolic (dysfunction) associated fatty liver disease","volume":"12","author":"Lu","year":"2023","journal-title":"Liver Cancer"},{"issue":"6","key":"10.1016\/j.asjsur.2024.03.147_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/apt.14218","article-title":"Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers","volume":"46","author":"Shaheen","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.asjsur.2024.03.147_bib37","series-title":"International Encyclopedia of Statistical Science","first-page":"1658","article-title":"Wilcoxon-signed-rank test","author":"Rey","year":"2011"},{"issue":"9","key":"10.1016\/j.asjsur.2024.03.147_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00691-18","article-title":"Combination of tenofovir and emtricitabine with efavirenz does not moderate inhibitory effect of efavirenz on mitochondrial function and cholesterol biosynthesis in human T lymphoblastoid cell line","volume":"62","author":"Li","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.asjsur.2024.03.147_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00535-020-01750-3","article-title":"Tenofovir-disoproxil-fumarate modulates lipid metabolism via hepatic CD36\/PPAR-alpha activation in hepatitis B virus infection","volume":"56","author":"Suzuki","year":"2021","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.asjsur.2024.03.147_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102300","article-title":"Association between statin use and the prognosis of hepatocellular carcinoma after resection: a nationwide cohort study","volume":"65","author":"Jeon","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.asjsur.2024.03.147_bib41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.7326\/M18-2753","article-title":"Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis: results from a nationwide Swedish population","volume":"171","author":"Simon","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.asjsur.2024.03.147_bib42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cgh.2022.01.057","article-title":"Statin use and reduced hepatocellular carcinoma risk in patients with nonalcoholic fatty liver disease","volume":"21","author":"Zou","year":"2023","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Asian Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958424005748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958424005748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T15:23:07Z","timestamp":1730733787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1015958424005748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1015958424005748"],"URL":"https:\/\/doi.org\/10.1016\/j.asjsur.2024.03.147","relation":{},"ISSN":["1015-9584"],"issn-type":[{"value":"1015-9584","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of tenofovir versus entecavir on the long-term prognosis in hepatocellular carcinoma patients with concurrent metabolic dysfunction-associated steatotic liver disease and hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.asjsur.2024.03.147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Asian Surgical Association and Taiwan Society of Coloproctology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}